On this site you can find recent news about Profil. You can read more about Profil and our work as clinical research organization. Furthermore, we will discuss interesting topics that are of high interest to pharmaceutical or technology companies innovating in the diabetes field.
For any questions or comments, please feel free to contact us using the contact button on the right.
November 11, 2021
Are GLP1 receptor agonists a treatment option in patients with non-alcoholic fatty liver disease (NAFLD)? Nowadays many potential treatment options for diabetes mellitus are being evaluated for other
October 13, 2021
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Free live
October 5, 2021
Profil continues the successful series of scientific online seminars. On November 2nd, 2021 at 4 PM CEST we will air our next free online seminar. The session is presented by Dr. Eric Zijlstra,
September 23, 2021
In a review article published in April 2021, Profil’s Lead Scientist Dr. Tim Heise gives an overview on the future of insulin therapy (1). When thinking of 100 years of insulin treatment since its
August 9, 2021
On the 2nd of August 2021 EMA published the start of the countdown to go-live for the Clinical Trials Information System (CTIS) (1). The countdown comprises 6 months and will end on 31 January 2022.
July 12, 2021
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Upcoming
June 2, 2021
A Remote Decentralised Clinical Trial (RDCT) design can be a valuable option to make your clinical trial more efficient. Also called web-based or hybrid trials, they combine digital technologies with
May 7, 2021
One of the aspects to consider when designing clinical trials, and often a quite controversial one, is the ratio of male and female study participants. There are a number of criteria that can have an